Epigenetic factors regulate RNA polymerase II transcription Trypanosoma brucei
表观遗传因子调节 RNA 聚合酶 II 转录 布氏锥虫
基本信息
- 批准号:9063049
- 负责人:
- 金额:$ 5.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:AfricaAfrican TrypanosomiasisAntisense RNABiological AssayCattleCell divisionCellsCharacteristicsCodeCulture MediaDNADNA SequenceDataDissociationDown-RegulationDrug TargetingEpigenetic ProcessEukaryotaEventExcisionExhibitsFutureGene Expression RegulationGene MutationGenesGenetic TranscriptionHealthHigh Density LipoproteinsHumanInfectionLaboratoriesLeadLeftLeishmaniaLightLyticMediatingNatureNucleotidesOrganismParasitesParasitic DiseasesPharmaceutical PreparationsPhenotypePlayPolymerasePredispositionProcessPromoter RegionsRNA Polymerase IIRNA interference screenRegulationRegulatory ElementReportingRepressionResistanceRoleSystemTestingThymidineTranscriptTranscription InitiationTranscriptional RegulationTrypanosomaTrypanosoma brucei bruceiUntranslated RNAbasecombatdrug developmentgene repressionin vivomRNA Stabilitynervous system disordernew therapeutic targetnovelpromoterreceptortranscription termination
项目摘要
DESCRIPTION (provided by applicant): Trypanosoma brucei is a single cell protozoan parasite that infects humans and cattle in parts of Africa. Humans infected with T. brucei suffer from a severe neurological disease called African sleeping sickness that is inadvertently fatal when left untreated. Chemotherapeutic drugs against this parasite are few, relatively toxic, and logistically difficult to administer. The need to identify new drug targets and develop better medications is therefore urgent. This proposal will identify unique aspects of gene regulation in T. brucei, discovering novel mechanisms as potential drug targets. Unlike other eukaryotes, genes transcribed by RNA polymerase II (Pol II) in trypanosomes are arranged in large polycistronic transcription units (PTU) as long primary RNAs. Little is known about regulation of transcription initiation or termination. However, recent evidence indicates that epigenetic factors and especially base J, a hyper-modified nucleotide plays a significant role in regulation of Pol II
mediated transcription. We have identified regulation of transcription initiation as well as evidence of regulated transcription termination. I propose two aims to study these modes of repression and the epigenetic mechanisms that are involved.
描述(由申请方提供):布氏锥虫是一种单细胞原生动物寄生虫,在非洲部分地区感染人类和牛。感染T.布氏病是一种严重的神经系统疾病,称为非洲昏睡病,如果不及时治疗,会致命。针对这种寄生虫的化学药物很少,毒性相对较大,并且难以管理。因此,迫切需要确定新的药物靶点并开发更好的药物。这一建议将确定独特的方面的基因调控T。布氏杆菌,发现新的机制作为潜在的药物靶点。 与其他真核生物不同,在锥虫中由RNA聚合酶II(Pol II)转录的基因以大的多顺反子转录单位(PTU)排列为长的初级RNA。对转录起始或终止的调控知之甚少。然而,最近的证据表明,表观遗传因素,特别是碱基J,一种高度修饰的核苷酸,在Pol II的调节中起着重要作用
介导的转录我们已经确定了转录起始的调节以及调节转录终止的证据。我提出了两个目标,研究这些模式的镇压和表观遗传机制所涉及的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica Lopes da Rosa-Spiegler其他文献
Jessica Lopes da Rosa-Spiegler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica Lopes da Rosa-Spiegler', 18)}}的其他基金
Epigenetic factors regulate RNA polymerase II transcription Trypanosoma brucei
表观遗传因子调节 RNA 聚合酶 II 转录 布氏锥虫
- 批准号:
8718574 - 财政年份:2014
- 资助金额:
$ 5.8万 - 项目类别:
Epigenetic factors regulate RNA polymerase II transcription Trypanosoma brucei
表观遗传因子调节 RNA 聚合酶 II 转录 布氏锥虫
- 批准号:
8904293 - 财政年份:2014
- 资助金额:
$ 5.8万 - 项目类别:
相似海外基金
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
- 批准号:
10511408 - 财政年份:2022
- 资助金额:
$ 5.8万 - 项目类别:
A One Health approach to investigating the ecology of East African trypanosomiasis in Malawian wildlife
调查马拉维野生动物中东非锥虫病生态学的“同一个健康”方法
- 批准号:
476178 - 财政年份:2022
- 资助金额:
$ 5.8万 - 项目类别:
Studentship Programs
The catalytic core of the proteasome as a drug target to treat Human African Trypanosomiasis
蛋白酶体的催化核心作为治疗非洲人类锥虫病的药物靶点
- 批准号:
10677879 - 财政年份:2022
- 资助金额:
$ 5.8万 - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10466942 - 财政年份:2021
- 资助金额:
$ 5.8万 - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10296873 - 财政年份:2021
- 资助金额:
$ 5.8万 - 项目类别:
Multi-target approach to rational design of novel therapeutics for human African trypanosomiasis
多目标方法合理设计非洲人类锥虫病新疗法
- 批准号:
10706306 - 财政年份:2021
- 资助金额:
$ 5.8万 - 项目类别:
Reducing and replacing the animal cost of functional genetics in African trypanosomiasis
减少和替代非洲锥虫病功能遗传学的动物成本
- 批准号:
NC/W001144/1 - 财政年份:2021
- 资助金额:
$ 5.8万 - 项目类别:
Research Grant
Development of new drug for African trypanosomiasis based on elucidation of the mechanism of antiprotozoal action by ribavirin.
基于利巴韦林抗原虫作用机制的阐明,开发治疗非洲锥虫病的新药。
- 批准号:
21K18230 - 财政年份:2021
- 资助金额:
$ 5.8万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Development of a novel control measure for African trypanosomiasis based on the blocking of lifecycle progression
基于生命周期进展阻断的非洲锥虫病新型控制措施的开发
- 批准号:
20K07467 - 财政年份:2020
- 资助金额:
$ 5.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Drug-diagnostic co-development in Tropical Medicine, combating Human African Trypanosomiasis
热带医学药物诊断联合开发,抗击非洲人类锥虫病
- 批准号:
18KK0454 - 财政年份:2019
- 资助金额:
$ 5.8万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))














{{item.name}}会员




